Mark Trudeau Healthcare News

This is selected healthcare news for Mark Trudeau, which is filed under People. There are 44 news items for this page. A press release filter page is also available for Mark Trudeau.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
6/16/2022 Mallinckrodt Emerges from Chapter 11 with Strengthened Balance Sheet and Enhanced Financial Flexibility
... R&D organization in the UK and U.S., focused on branded drug development, and served as Head of Drug Development for Omega Farma in Iceland . Mark Trudeau has stepped down from his role as President and CEO, effective today. Mallinckrodt has established an Office of the CEO on an interim ...
PR Newswire
3/23/2022 Silence Therapeutics and Mallinckrodt Announce Submission of Clinical Trial Application for SLN501
... mediated diseases. This highlights the importance of partnerships to expand our pipeline opportunities while also providing non-dilutive financing to support our development activities.‚Au Mark Trudeau, President and Chief Executive Officer of Mallinckrodt, said: ‚AuWe remain excited about the potential of Silence's mRNAi GOLD‚N¢ platform to address ...
Business Wire
2/4/2022 Mallinckrodt Plan of Reorganization Confirmed by U.S. Court
... by the U.S. Bankruptcy Court for the District of Delaware , paving the way for the Company to begin the next stage in its reorganization process. Mark Trudeau , President and Chief Executive Officer of Mallinckrodt , said, "We are pleased to have achieved this significant milestone in the Company's reorganization. We appreciate ...
Yahoo News
2/4/2022 Mallinckrodt Plan of Reorganization Confirmed by U.S. Court
... by the U.S. Bankruptcy Court for the District of Delaware , paving the way for the Company to begin the next stage in its reorganization process. Mark Trudeau , President and Chief Executive Officer of Mallinckrodt , said, "We are pleased to have achieved this significant milestone in the Company's reorganization. We appreciate ...
PR Newswire
8/29/2020 Options trading Mallinckrodt crashes 34% after saying it might file for Chapter 11 bankruptcy due to opioid litigation (MNK)
... to Medicaid related to its Acthar Gel product. “Looking ahead, we expect our current challenges to continue in the back half of the year,” CEO Mark Trudeau said. Mallinckrodt shares are down 58% year-to-date. Mallinckrodt investors may be left holding the bag after the pharmaceutical company said in ...
marketanalysisnews.com
8/4/2020 Mallinckrodt crashes 34% as it might file for Chapter 11 bankruptcy - Business Insider
... to Medicaid related to its Acthar Gel product. "Looking ahead, we expect our current challenges to continue in the back half of the year," CEO Mark Trudeau said. Mallinckrodt shares are down 58% year-to-date. Mallinckrodt investors may be left holding the bag after the pharmaceutical company said in ...
Business Insider
6/17/2020 Mallinckrodt to Present at the BMO Prescriptions for Success Healthcare Conference
STAINES-UPON-THAMES, United Kingdom , June 17, Mallinckrodt plc (NYSE: MNK ), a global biopharmaceutical company, will present on Tuesday, June 23, 2020 at the BMO Prescriptions for Success Healthcare Conference. Mark Trudeau , President and Chief Executive Officer, and Bryan Reasons , Executive Vice President and Chief Financial Officer, will represent the ...
PR Newswire
5/6/2020 Mallinckrodt (MNK) Q1 2020 Earnings Call Transcript | The Motley Fool
... President of Investor Relations Thank you, Brandy. Good morning, everyone, and welcome to our first-quarter 2020 earnings conference call. Joining me this morning are Mark Trudeau, CEO; Steven Romano, our chief scientific officer; and Bryan Reasons, our CFO. Before we begin, let me remind you of a few important ...
fool.com
5/5/2020 Mallinckrodt plc Reports Earnings for the First Quarter 2020 and Highlights Pipeline Progress
... As we navigate the unprecedented challenges created by the COVID-19 pandemic, we are committed to ensuring patients have uninterrupted access to our medicines," said Mark Trudeau , President and Chief Executive Officer of Mallinckrodt . "I am proud of Mallinckrodt's ability to continue manufacturing and supplying products during this critical time ...
PR Newswire
3/25/2020 OpenVault Launches Suite to Remotely ID, Resolve Customer Issues
OpenVault Launches Suite to Remotely ID, Resolve Customer Issues Share Article Distance Diagnostics/Remote Care to heighten safety for tech workforce, customers In a socially-distant world, consumers are turning more than ever to broadband for work, education and entertainment,” said Mark Trudeau, CEO and founder of OpenVault. HOBOKEN, N.J ...
PRWeb
3/11/2020 Mallinckrodt president says company will weather $1.6 billion opioid litigation settlement
... we have continued to deliver strong earnings and cash flow as evidenced by our fourth quarter and 2019 results issued today,” Mallinckrodt president and CEO Mark Trudeau said in a statement provided to the St. Louis Record. “Looking ahead, we remain focused on our vision to develop and bring to ...
stlrecord.com
2/25/2020 Mallinckrodt plc Reports Strong Fourth Quarter and 2019 Results
... diluted EPS was $2.40 versus $2.18 , an increase of 10.1%. "We are pleased with the operating strength of the business as we finished 2019," said Mark Trudeau , President and Chief Executive Officer of Mallinckrodt . "Our hospital products had an exceptional fourth quarter, as we anticipated, and the Specialty Generics segment ...
PR Newswire
1/15/2020 Mallinckrodt’s stocks soars on heavy volume toward near-40% gain this week after comments at broker conference
... transcript provided by FactSet. "So, we don't feel it's in our best interest to actually initiate the settlements." And regarding the opioid litigations, Chief Executive Mark Trudeau said he was "hopeful" that a resolution can be reached "sooner rather than later." The stock has more than doubled (up 110%) over ...
MarketWatch
12/23/2019 Mallinckrodt to Present at the 38th Annual J.P. Morgan Healthcare Conference
STAINES-UPON-THAMES, United Kingdom , Dec. 23, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK ), a global biopharmaceutical company, announced today that Mark Trudeau , President and Chief Executive Officer, and other members of management will represent the company at the 38th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis on ...
PR Newswire
12/23/2019 Mallinckrodt to Present at the 38th Annual J.P. Morgan Healthcare Conference
Reblog STAINES-UPON-THAMES, United Kingdom , Dec. 23, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, announced today that Mark Trudeau , President and Chief Executive Officer, and other members of management will represent the company at the 38th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis ...
Yahoo News
12/23/2019 Mallinckrodt to Present at the 38th Annual J.P. Morgan Healthcare Conference
PR Newswire STAINES-UPON-THAMES, United Kingdom, Dec. 23, 2019 STAINES-UPON-THAMES, United Kingdom Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, announced today that Mark Trudeau , President and Chief Executive Officer, and other members of management will represent the company at the 38th Annual J.P. Morgan Healthcare Conference ...
gurufocus.com
12/3/2019 Mallinckrodt Moves Date and Time of Its Fireside Chat at Piper Jaffray Annual Healthcare Conference
STAINES-UPON-THAMES, United Kingdom , Dec. 2, Mallinckrodt plc (NYSE: MNK ), a global biopharmaceutical company, announced today that the Company now will present at the Piper Jaffray Annual Healthcare Conference on Wednesday, Dec. 4, 2019 at 12:30 p.m. Eastern. Mark Trudeau , President and Chief Executive Officer, and Steven Romano , M.D ...
PR Newswire
12/3/2019 Mallinckrodt Moves Date and Time of Its Fireside Chat at Piper Jaffray Annual Healthcare Conference
... that the Company now will present at the Piper Jaffray Annual Healthcare Conference on Wednesday, Dec. 4, 2019 at 12:30 p.m. Eastern. Mallinckrodt logo More Mark Trudeau , President and Chief Executive Officer, and Steven Romano , M.D., Executive Vice President and Chief Scientific Officer, will represent the company in a fireside ...
Yahoo News
12/3/2019 Mallinckrodt Moves Date and Time of Its Fireside Chat at Piper Jaffray Annual Healthcare Conference
... company, announced today that the Company now will present at the Piper Jaffray Annual Healthcare Conference on Wednesday, Dec. 4, 2019 at 12:30 p.m. Eastern. Mark Trudeau , President and Chief Executive Officer, and Steven Romano , M.D., Executive Vice President and Chief Scientific Officer, will represent the company in a fireside ...
vporoom.com
12/3/2019 Mallinckrodt Moves Date and Time of Its Fireside Chat at Piper Jaffray Annual Healthcare Conference
... company, announced today that the Company now will present at the Piper Jaffray Annual Healthcare Conference on Wednesday, Dec. 4, 2019 at 12:30 p.m. Eastern. Mark Trudeau , President and Chief Executive Officer, and Steven Romano , M.D., Executive Vice President and Chief Scientific Officer, will represent the company in a fireside ...
BioSpace
12/2/2019 Mallinckrodt Moves Date and Time of Its Fireside Chat at Piper Jaffray Annual Healthcare Conference
STAINES-UPON-THAMES, United Kingdom , Dec. 2, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, announced today that the Company now will present at the Piper Jaffray Annual Healthcare Conference on Wednesday, Dec. 4, 2019 at 12:30 p.m. Eastern. Mark Trudeau , President and Chief Executive Officer, and Steven ...
Business Insider
12/2/2019 Mallinckrodt Moves Date and Time of Its Fireside Chat at Piper Jaffray Annual Healthcare Conference
STAINES-UPON-THAMES, United Kingdom Mallinckrodt plc ( NYSE: MNK ), a global biopharmaceutical company, announced today that the Company now will present at the Piper Jaffray Annual Healthcare Conference on Wednesday, Dec. 4, 2019 at 12:30 p.m. Eastern. Mark Trudeau , President and Chief Executive Officer, and Steven Romano , M.D., Executive Vice ...
wapakdailynews.com
12/2/2019 Mallinckrodt Moves Date and Time of Its Fireside Chat at Piper Jaffray Annual Healthcare Conference
... company, announced today that the Company now will present at the Piper Jaffray Annual Healthcare Conference on Wednesday, Dec. 4, 2019 at 12:30 p.m. Eastern. Mark Trudeau , President and Chief Executive Officer, and Steven Romano , M.D., Executive Vice President and Chief Scientific Officer, will represent the company in a fireside ...
gurufocus.com
11/19/2019 Mallinckrodt to Present at Piper Jaffray Annual Healthcare Conference
STAINES-UPON-THAMES, United Kingdom , Nov. 19, Mallinckrodt plc (NYSE: MNK ), a global biopharmaceutical company, will present on Tuesday, Dec. 3, 2019 , at the Piper Jaffray Annual Healthcare Conference at the Lotte New York Palace, 455 Madison Ave, New York. Mark Trudeau , President and Chief Executive Officer, and Steven Romano ...
PR Newswire
11/19/2019 Mallinckrodt to Present at Piper Jaffray Annual He
... will present on Tuesday, Dec. 3, 2019 , at the Piper Jaffray Annual Healthcare Conference at the Lotte New York Palace, 455 Madison Ave, New York. Mark Trudeau , President and Chief Executive Officer, and Steven Romano , M.D., Executive Vice President and Chief Scientific Officer, will represent the company in a fireside ...
newyorklatinonews.com